BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3731740)

  • 1. [Medical therapy of portal hypertension].
    Baldassarre G; Ventrella F; Gadaleta CD
    Clin Ter; 1986 May; 117(4):355-60. PubMed ID: 3731740
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
    Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol therapy for portal hypertension in children.
    Ozsoylu S; Koçak N; Yüce A
    J Pediatr; 1985 Feb; 106(2):317-21. PubMed ID: 3968624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoprolol in portal hypertension. A controlled study.
    Bützow GH; Remmecke J; Bräuer A
    Klin Wochenschr; 1982 Oct; 60(20):1311-4. PubMed ID: 7144066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal-systemic encephalopathy and gastrointestinal bleeding after cardioselective beta-blocker (metoprolol) administration to patients with portal hypertension.
    Uribe M; Orozco H; Morán S; Guevara L; Poo JL; Vargas-Vorackova F
    Arch Med Res; 1995; 26(3):221-6. PubMed ID: 8580671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in portal hypertension.
    Menghini G
    Hepatology; 1983; 3(3):466. PubMed ID: 6840693
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol in portal hypertension.
    Lacaine F
    Hepatology; 1983; 3(4):622-3. PubMed ID: 6345334
    [No Abstract]   [Full Text] [Related]  

  • 11. Propranolol effect on portal hypertension.
    Ozsoylu S
    Hepatology; 1988; 8(3):707. PubMed ID: 3371890
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Propranolol treatment of hemorrhage due to portal hypertension].
    Bleichner G; Parent A; Raffray Y; Squara P
    Nouv Presse Med; 1981 Mar; 10(13):1072-3. PubMed ID: 6971437
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment of hemorrhage in portal hypertension of the cirrhotic patient using propanolol].
    Chevrel B
    Med Chir Dig; 1982; 11(1):69-70, 73-5. PubMed ID: 6979665
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of propranolol in portal hypertension. Conventional and long acting formulations.
    Hayes PC
    Drugs; 1989; 37 Suppl 2():70-3; discussion 74-6. PubMed ID: 2680433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
    Rocher I; Decourt S; Leneveu A; Lebrec D; Rosier SP; Flouvat B
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):406-10. PubMed ID: 4044073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters.
    Gitlin N
    Am J Gastroenterol; 1983 Feb; 78(2):124-6. PubMed ID: 6823937
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment options in portal hypertension: Does propranolol have a role? Proceedings of a satellite symposium of the XIII International Congress of Gastroenterology and the VI European Congress of Digestive Endoscopy. Rome, 9 September 1988.
    Drugs; 1989; 37 Suppl 2():1-73. PubMed ID: 2806132
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of intravenous propranolol on portal hypertension.
    Gupta KM; Chadda S; Chadda VS; Panwar RB; Sharda DP; Mishra SN; Chaudhary A
    J Assoc Physicians India; 1984 Apr; 32(4):343-4. PubMed ID: 6746547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.